Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL4871106 (M-2698, M2698, Msc-2363318a, MSC-2363318A, MSC2363318A) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
aurora kinase B/Aurora kinase B/Inner centromere protein in Human (target type: PROTEIN COMPLEX) [ChEMBL: CHEMBL3430907] [GtoPdb: 1937] [UniProtKB: Q96GD4, Q9NQS7] | ||||||||
ChEMBL | Inhibition of recombinant full length GST-tagged human Aurora B (1 to 344 residues) co-expressed with N-terminal His-tagged human recombinant INCENP (803 to 918 residues) in baculovirus infected Sf21 cells incubated for 90 mins by mobility shift assay | B | 6.77 | pIC50 | 170 | nM | IC50 | J Med Chem (2021) 64: 14603-14619 [PMID:34596404] |
AKT serine/threonine kinase 1/Serine/threonine-protein kinase AKT in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4282] [GtoPdb: 1479] [UniProtKB: P31749] | ||||||||
ChEMBL | Inhibition of His-tagged human AKT1 expressed in baculovirus expression system using TC-AHA-GRPRTSSFAEG-NH2 as substrate incubated for 90 mins by mobility shift assay | B | 8.4 | pIC50 | 4 | nM | IC50 | J Med Chem (2021) 64: 14603-14619 [PMID:34596404] |
GtoPdb | - | - | 9 | pIC50 | 1 | nM | IC50 | Am J Cancer Res (2016) 6: 806-18 [PMID:27186432] |
ribosomal protein S6 kinase B1 in Human [GtoPdb: 1525] [UniProtKB: P23443] | ||||||||
GtoPdb | - | - | 9 | pIC50 | 1 | nM | IC50 | Am J Cancer Res (2016) 6: 806-18 [PMID:27186432] |
AKT serine/threonine kinase 3 in Human [GtoPdb: 2286] [UniProtKB: Q9Y243] | ||||||||
GtoPdb | - | - | 9 | pIC50 | 1 | nM | IC50 | Am J Cancer Res (2016) 6: 806-18 [PMID:27186432] |
ChEMBL data shown on this page come from version 33:
Mendez D, Gaulton A, Bento AP, Chambers J, De Veij M, Félix E, Magariños MP, Mosquera JF, Mutowo P, Nowotka M, Gordillo-Marañón M, Hunter F, Junco L, Mugumbate G, Rodriguez-Lopez M, Atkinson F, Bosc N, Radoux CJ, Segura-Cabrera A, Hersey A, Leach AR. (2019) 'ChEMBL: towards direct deposition of bioassay data' Nucleic Acids Res., 47(D1). DOI: 10.1093/nar/gky1075. [EPMCID:30398643]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]